Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2024-09-03 Sale |
2024-09-04 8:42 pm |
Kiniksa Pharmaceuticals International plc | KNSA | Moat Ross CHIEF COMMERCIAL OFFICER |
68,506 | $26.12 | $1,789,190 | 125,037 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2025-04-07 Exercise |
2025-04-09 4:42 pm |
N/A N/A |
Kiniksa Pharmaceuticals International plc | KNSA | Moat Ross CHIEF COMMERCIAL OFFICER |
2,477 | $0 | 30,151 (Direct) |
View |
| 2025-04-07 Tax Withholding |
2025-04-09 4:42 pm |
N/A N/A |
Kiniksa Pharmaceuticals International plc | KNSA | Moat Ross CHIEF COMMERCIAL OFFICER |
727 | $20.28 | 30,151 (Direct) |
View |
| 2025-04-01 Option Award |
2025-04-03 5:06 pm |
N/A 2035-03-31 |
Kiniksa Pharmaceuticals International plc | KNSA | Moat Ross CHIEF COMMERCIAL OFFICER |
68,849 | $0 | 103,216 (Direct) |
View |
| 2025-04-01 Exercise |
2025-04-03 5:06 pm |
N/A N/A |
Kiniksa Pharmaceuticals International plc | KNSA | Moat Ross CHIEF COMMERCIAL OFFICER |
3,352 | $0 | 103,216 (Direct) |
View |
| 2025-04-01 Tax Withholding |
2025-04-03 5:06 pm |
N/A N/A |
Kiniksa Pharmaceuticals International plc | KNSA | Moat Ross CHIEF COMMERCIAL OFFICER |
984 | $21.77 | 103,216 (Direct) |
View |
| 2025-01-15 Option Award |
2025-03-19 5:52 pm |
N/A N/A |
Kiniksa Pharmaceuticals International plc | KNSA | Moat Ross CHIEF COMMERCIAL OFFICER |
1,118 | $16 | 23,556 (Direct) |
View |
| 2025-03-16 Tax Withholding |
2025-03-19 5:52 pm |
N/A N/A |
Kiniksa Pharmaceuticals International plc | KNSA | Moat Ross CHIEF COMMERCIAL OFFICER |
292 | $22.61 | 23,556 (Direct) |
View |
| 2025-03-16 Exercise |
2025-03-19 5:52 pm |
N/A N/A |
Kiniksa Pharmaceuticals International plc | KNSA | Moat Ross CHIEF COMMERCIAL OFFICER |
994 | $0 | 23,556 (Direct) |
View |
| 2024-09-01 Option Award |
2024-09-04 8:42 pm |
N/A N/A |
Kiniksa Pharmaceuticals International plc | KNSA | Moat Ross CHIEF COMMERCIAL OFFICER |
43,062 | $0 | 125,037 (Direct) |
View |
| 2024-09-03 Exercise |
2024-09-04 8:42 pm |
N/A N/A |
Kiniksa Pharmaceuticals International plc | KNSA | Moat Ross CHIEF COMMERCIAL OFFICER |
29,730 | $11.1 | 125,037 (Direct) |
View |
| 2024-09-01 Exercise |
2024-09-04 8:42 pm |
N/A N/A |
Kiniksa Pharmaceuticals International plc | KNSA | Moat Ross CHIEF COMMERCIAL OFFICER |
77,678 | $0 | 125,037 (Direct) |
View |
| 2024-09-03 Exercise |
2024-09-04 8:42 pm |
N/A N/A |
Kiniksa Pharmaceuticals International plc | KNSA | Moat Ross CHIEF COMMERCIAL OFFICER |
24,776 | $11.97 | 125,037 (Direct) |
View |
| 2024-09-03 Exercise |
2024-09-04 8:42 pm |
N/A N/A |
Kiniksa Pharmaceuticals International plc | KNSA | Moat Ross CHIEF COMMERCIAL OFFICER |
14,000 | $8.83 | 125,037 (Direct) |
View |
| 2024-09-01 Tax Withholding |
2024-09-04 8:42 pm |
N/A N/A |
Kiniksa Pharmaceuticals International plc | KNSA | Moat Ross CHIEF COMMERCIAL OFFICER |
1,738 | $26.74 | 125,037 (Direct) |
View |
| 2024-07-15 Option Award |
2024-09-04 8:42 pm |
N/A N/A |
Kiniksa Pharmaceuticals International plc | KNSA | Moat Ross CHIEF COMMERCIAL OFFICER |
211 | $15.65 | 125,037 (Direct) |
View |
| 2024-04-04 Option Award |
2024-04-08 5:19 pm |
N/A 2034-03-31 |
Kiniksa Pharmaceuticals Ltd. | KNSA | Moat Ross CHIEF COMMERCIAL OFFICER |
48,631 | $0 | 79,058 (Direct) |
View |
| 2024-04-08 Tax Withholding |
2024-04-08 5:19 pm |
N/A N/A |
Kiniksa Pharmaceuticals Ltd. | KNSA | Moat Ross CHIEF COMMERCIAL OFFICER |
1,353 | $17.9 | 79,058 (Direct) |
View |
| 2024-04-08 Exercise |
2024-04-08 5:19 pm |
N/A N/A |
Kiniksa Pharmaceuticals Ltd. | KNSA | Moat Ross CHIEF COMMERCIAL OFFICER |
2,477 | $0 | 79,058 (Direct) |
View |
| 2024-04-01 Tax Withholding |
2024-04-03 5:20 pm |
N/A N/A |
Kiniksa Pharmaceuticals Ltd. | KNSA | Moat Ross CHIEF COMMERCIAL OFFICER |
880 | $19.7 | 19,985 (Direct) |
View |
| 2024-04-01 Exercise |
2024-04-03 5:20 pm |
N/A N/A |
Kiniksa Pharmaceuticals Ltd. | KNSA | Moat Ross CHIEF COMMERCIAL OFFICER |
1,612 | $0 | 19,985 (Direct) |
View |
| 2023-09-01 Option Award |
2023-09-06 7:07 pm |
N/A N/A |
Kiniksa Pharmaceuticals Ltd. | KNSA | Moat Ross CHIEF COMMERCIAL OFFICER |
45,113 | $0 | 68,952 (Direct) |
View |
| 2023-07-15 Option Award |
2023-09-06 7:07 pm |
N/A N/A |
Kiniksa Pharmaceuticals Ltd. | KNSA | Moat Ross CHIEF COMMERCIAL OFFICER |
292 | $12.35 | 68,952 (Direct) |
View |
| 2023-09-01 Tax Withholding |
2023-09-06 7:07 pm |
N/A N/A |
Kiniksa Pharmaceuticals Ltd. | KNSA | Moat Ross CHIEF COMMERCIAL OFFICER |
1,896 | $17.76 | 68,952 (Direct) |
View |
| 2023-09-01 Exercise |
2023-09-06 7:07 pm |
N/A N/A |
Kiniksa Pharmaceuticals Ltd. | KNSA | Moat Ross CHIEF COMMERCIAL OFFICER |
3,471 | $0 | 68,952 (Direct) |
View |
| 2023-04-10 Tax Withholding |
2023-04-11 5:06 pm |
N/A N/A |
Kiniksa Pharmaceuticals Ltd. | KNSA | Moat Ross CHIEF COMMERCIAL OFFICER |
1,353 | $10.71 | 19,984 (Direct) |
View |
| 2023-04-10 Exercise |
2023-04-11 5:06 pm |
N/A N/A |
Kiniksa Pharmaceuticals Ltd. | KNSA | Moat Ross CHIEF COMMERCIAL OFFICER |
2,477 | $0 | 19,984 (Direct) |
View |
| 2023-04-01 Option Award |
2023-04-03 4:30 pm |
N/A 2033-03-31 |
Kiniksa Pharmaceuticals Ltd. | KNSA | Moat Ross CHIEF COMMERCIAL OFFICER |
45,113 | $0 | 45,113 (Direct) |
View |
| 2023-03-16 Tax Withholding |
2023-03-20 5:19 pm |
N/A N/A |
Kiniksa Pharmaceuticals Ltd. | KNSA | Moat Ross CHIEF COMMERCIAL OFFICER |
543 | $11.46 | 13,417 (Direct) |
View |
| 2023-03-16 Exercise |
2023-03-20 5:19 pm |
N/A N/A |
Kiniksa Pharmaceuticals Ltd. | KNSA | Moat Ross CHIEF COMMERCIAL OFFICER |
3,131 | $0 | 13,417 (Direct) |
View |
| 2023-01-15 Option Award |
2023-03-20 5:19 pm |
N/A N/A |
Kiniksa Pharmaceuticals Ltd. | KNSA | Moat Ross CHIEF COMMERCIAL OFFICER |
1,844 | $9.56 | 13,417 (Direct) |
View |
| 2023-03-20 Tax Withholding |
2023-03-20 5:19 pm |
N/A N/A |
Kiniksa Pharmaceuticals Ltd. | KNSA | Moat Ross CHIEF COMMERCIAL OFFICER |
1,167 | $11.12 | 13,417 (Direct) |
View |
| 2022-09-01 Option Award |
2022-09-06 4:12 pm |
N/A 2032-08-31 |
Kiniksa Pharmaceuticals Ltd. | KNSA | Moat Ross CHIEF COMMERCIAL OFFICER |
69,368 | $0 | 80,514 (Direct) |
View |
| 2022-09-02 Exercise |
2022-09-06 4:12 pm |
N/A N/A |
Kiniksa Pharmaceuticals Ltd. | KNSA | Moat Ross CHIEF COMMERCIAL OFFICER |
995 | $0 | 80,514 (Direct) |
View |
| 2022-07-15 Option Award |
2022-09-06 4:12 pm |
N/A N/A |
Kiniksa Pharmaceuticals Ltd. | KNSA | Moat Ross CHIEF COMMERCIAL OFFICER |
360 | $9.56 | 80,514 (Direct) |
View |
| 2022-09-02 Tax Withholding |
2022-09-06 4:12 pm |
N/A N/A |
Kiniksa Pharmaceuticals Ltd. | KNSA | Moat Ross CHIEF COMMERCIAL OFFICER |
563 | $11.44 | 80,514 (Direct) |
View |
| 2022-04-07 Option Award |
2022-04-11 4:30 pm |
N/A 2032-04-06 |
Kiniksa Pharmaceuticals Ltd. | KNSA | Moat Ross CHIEF COMMERCIAL OFFICER |
69,368 | $0 | 69,368 (Direct) |
View |
| 2022-03-21 Exercise |
2022-03-23 4:30 pm |
N/A N/A |
Kiniksa Pharmaceuticals Ltd. | KNSA | Moat Ross CHIEF COMMERCIAL OFFICER |
2,270 | $0 | 7,372 (Direct) |
View |
| 2022-03-21 Tax Withholding |
2022-03-23 4:30 pm |
N/A N/A |
Kiniksa Pharmaceuticals Ltd. | KNSA | Moat Ross CHIEF COMMERCIAL OFFICER |
1,240 | $10.98 | 7,372 (Direct) |
View |
| 2022-03-16 Tax Withholding |
2022-03-18 4:39 pm |
N/A N/A |
Kiniksa Pharmaceuticals Ltd. | KNSA | Moat Ross Chief Commercial Officer |
544 | $10.13 | 9,324 (Direct) |
View |
| 2022-01-15 Option Award |
2022-03-18 4:39 pm |
N/A N/A |
Kiniksa Pharmaceuticals Ltd. | KNSA | Moat Ross Chief Commercial Officer |
1,546 | $9.63 | 9,324 (Direct) |
View |
| 2022-03-16 Exercise |
2022-03-18 4:39 pm |
N/A N/A |
Kiniksa Pharmaceuticals Ltd. | KNSA | Moat Ross Chief Commercial Officer |
995 | $0 | 9,324 (Direct) |
View |
| 2021-07-15 Option Award |
2022-03-18 4:39 pm |
N/A N/A |
Kiniksa Pharmaceuticals Ltd. | KNSA | Moat Ross Chief Commercial Officer |
963 | $11.49 | 9,324 (Direct) |
View |
| 2021-09-02 Option Award |
2021-09-07 5:16 pm |
N/A 2031-09-01 |
Kiniksa Pharmaceuticals Ltd. | KNSA | Moat Ross ARCALYST General Manager |
11,931 | $0 | 11,931 (Direct) |
View |
Ownership |
2021-04-15 5:32 pm |
N/A N/A |
Kiniksa Pharmaceuticals Ltd. | KNSA | Moat Ross Group VP & Rilonacept GM |
0 | $0 | 109,720 (Direct) |
View |